Table 3.
Sensitivity analyses of the reverse MR study
Exposure | Outcome | SNP (n) | Heterogeneity tests | Cochran’s Q | P value | Horizontal pleiotropy tests | Intercept | P value |
---|---|---|---|---|---|---|---|---|
Migraine | AR | 12 | IVW | 8.118 | 0.703 | MR Egger intercept test | 0.001 | 0.426 |
MR Egger | 7.430 | 0.684 | MR-PRESSO global test | NA | 0.850 | |||
MA | AR | 8 | IVW | 10.557 | 0.159 | MR Egger intercept test | 0.000 | 0.874 |
MR Egger | 10.509 | 0.105 | MR-PRESSO global test | NA | 0.693 | |||
MO | AR | 10 | IVW | 8.774 | 0.458 | MR Egger intercept test | 0.002 | 0.126 |
MR Egger | 5.858 | 0.663 | MR-PRESSO global test | NA | 0.129 |
AR, allergic rhinitis; MA, migraine with aura; MO, migraine without aura; SNP, single nucleotide polymorphism; IVW, inverse variance weighted; MR-PRESSO, Mendelian randomization pleiotropy residual sum and outlier; NA, not available